R. Pérez-Álvarez

2.9k total citations
25 papers, 1.6k citations indexed

About

R. Pérez-Álvarez is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, R. Pérez-Álvarez has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in R. Pérez-Álvarez's work include Salivary Gland Disorders and Functions (10 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). R. Pérez-Álvarez is often cited by papers focused on Salivary Gland Disorders and Functions (10 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). R. Pérez-Álvarez collaborates with scholars based in Spain, Argentina and United States. R. Pérez-Álvarez's co-authors include Manuel Ramos‐Casals, M. Pérez-de-Lis, Pilar Brito‐Zerón, Soledad Retamozo, Cándido Díaz‐Lagares, Albert Bové, Xavier Bosch, Miriam Akasbi, Francisco José García Hernández and Belchin Kostov and has published in prestigious journals such as The American Journal of Medicine, Journal of Hepatology and Annals of the Rheumatic Diseases.

In The Last Decade

R. Pérez-Álvarez

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Pérez-Álvarez Spain 19 640 599 488 343 302 25 1.6k
Cándido Díaz‐Lagares Spain 19 420 0.7× 704 1.2× 277 0.6× 346 1.0× 357 1.2× 25 1.5k
Soledad Retamozo Spain 22 757 1.2× 475 0.8× 318 0.7× 378 1.1× 246 0.8× 55 1.7k
M. Pérez-de-Lis Spain 17 446 0.7× 411 0.7× 263 0.5× 309 0.9× 242 0.8× 20 1.2k
Roser Solans Spain 19 699 1.1× 545 0.9× 411 0.8× 195 0.6× 154 0.5× 44 1.6k
Fengchun Zhang China 20 226 0.4× 440 0.7× 248 0.5× 215 0.6× 307 1.0× 68 1.3k
Micol Frassi Italy 17 197 0.3× 1.0k 1.7× 476 1.0× 146 0.4× 517 1.7× 31 1.6k
José María Pego‐Reigosa Spain 22 259 0.4× 959 1.6× 333 0.7× 179 0.5× 503 1.7× 82 1.6k
Carlotta Nannini Italy 21 534 0.8× 1.1k 1.9× 995 2.0× 366 1.1× 389 1.3× 38 2.1k
Yan Zhao China 29 327 0.5× 1.5k 2.5× 319 0.7× 595 1.7× 618 2.0× 116 2.5k
H M Moutsopoulos Greece 23 537 0.8× 587 1.0× 295 0.6× 135 0.4× 235 0.8× 43 1.3k

Countries citing papers authored by R. Pérez-Álvarez

Since Specialization
Citations

This map shows the geographic impact of R. Pérez-Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Pérez-Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Pérez-Álvarez more than expected).

Fields of papers citing papers by R. Pérez-Álvarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Pérez-Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Pérez-Álvarez. The network helps show where R. Pérez-Álvarez may publish in the future.

Co-authorship network of co-authors of R. Pérez-Álvarez

This figure shows the co-authorship network connecting the top 25 collaborators of R. Pérez-Álvarez. A scholar is included among the top collaborators of R. Pérez-Álvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Pérez-Álvarez. R. Pérez-Álvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brito‐Zerón, Pilar, R. Pérez-Álvarez, & Manuel Ramos‐Casals. (2022). Sarcoidosis. Medicina Clínica. 159(4). 195–204. 10 indexed citations
2.
Ramos‐Casals, Manuel, Soledad Retamozo, Antoni Sisó‐Almirall, et al.. (2019). Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Review of Clinical Immunology. 15(4). 391–405. 75 indexed citations
3.
Pérez-de-Lis, M., Soledad Retamozo, Alejandra Flores-Chávez, et al.. (2017). Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry). Expert Opinion on Drug Safety. 16(11). 1255–1271. 96 indexed citations
4.
Brito‐Zerón, Pilar, R. Pérez-Álvarez, Lucio Pallarés, et al.. (2016). Sarcoidosis: an update on current pharmacotherapy options and future directions. Expert Opinion on Pharmacotherapy. 17(18). 2431–2448. 32 indexed citations
5.
Bosch, Xavier, M. Pérez-de-Lis, R. Pérez-Álvarez, et al.. (2015). Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies. Seminars in Arthritis and Rheumatism. 45(4). 391–399. 40 indexed citations
6.
Gheitasi, H., Belchin Kostov, Roser Solans, et al.. (2015). How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients. International Immunopharmacology. 27(2). 194–199. 20 indexed citations
7.
Cárdenas, M.J. Soto, Myriam Gandía, Pilar Brito‐Zerón, et al.. (2014). Etiopathogenic Role of Surfactant Protein D in the Clinical and Immunological Expression of Primary Sjögren Syndrome. The Journal of Rheumatology. 42(1). 111–118. 4 indexed citations
8.
Brito‐Zerón, Pilar, Belchin Kostov, Roser Solans, et al.. (2014). Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Annals of the Rheumatic Diseases. 75(2). 348–355. 139 indexed citations
9.
Retamozo, Soledad, Miriam Akasbi, Pilar Brito‐Zerón, et al.. (2013). Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.. PubMed. 30(5). 686–92. 37 indexed citations
10.
Brito‐Zerón, Pilar, Soledad Retamozo, Miriam Akasbi, et al.. (2013). Annular erythema in primary Sjögren’s syndrome: description of 43 non-Asian cases. Lupus. 23(2). 166–175. 31 indexed citations
11.
Brito‐Zerón, Pilar, Miriam Akasbi, Xavier Bosch, et al.. (2013). Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome.. PubMed. 31(1). 103–10. 39 indexed citations
12.
Pérez-Álvarez, R., M. Pérez-de-Lis, & Manuel Ramos‐Casals. (2012). Biologics-induced autoimmune diseases. Current Opinion in Rheumatology. 25(1). 56–64. 127 indexed citations
13.
Akasbi, Miriam, Juan Berenguer, Albert Saiz, et al.. (2011). White matter abnormalities in primary Sjogren syndrome. QJM. 105(5). 433–443. 34 indexed citations
14.
Díaz‐Lagares, Cándido, R. Pérez-Álvarez, Francisco José García Hernández, et al.. (2011). Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label. Arthritis Research & Therapy. 13(4). R112–R112. 52 indexed citations
15.
Pérez-Álvarez, R., M. Pérez-de-Lis, Cándido Díaz‐Lagares, et al.. (2011). Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases. Seminars in Arthritis and Rheumatism. 41(2). 256–264. 206 indexed citations
16.
Pérez-Álvarez, R., Cándido Díaz‐Lagares, Francisco José García Hernández, et al.. (2011). Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy. Medicine. 90(6). 359–371. 210 indexed citations
17.
Ramos‐Casals, Manuel, R. Pérez-Álvarez, M. Pérez-de-Lis, Antoni Xaubet, & Xavier Bosch. (2011). Pulmonary Disorders Induced by Monoclonal Antibodies in Patients with Rheumatologic Autoimmune Diseases. The American Journal of Medicine. 124(5). 386–394. 39 indexed citations
18.
Pérez-de-Lis, M., Miriam Akasbi, Pilar Brito‐Zerón, et al.. (2010). Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients. Lupus. 19(8). 941–948. 68 indexed citations
19.
Ramos‐Casals, Manuel, Francisco José García Hernández, José Luís Callejas-Rubio, et al.. (2010). Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.. PubMed. 28(4). 468–76. 102 indexed citations
20.
González‐Gay, Miguel Á., José A. Miranda‐Filloy, Maria J. Lopez‐Diaz, et al.. (2007). Giant Cell Arteritis in Northwestern Spain. Medicine. 86(2). 61–68. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cándido Díaz‐Lagares Breakdown of academic impact, for papers by Soledad Retamozo Breakdown of academic impact, for papers by M. Pérez-de-Lis Breakdown of academic impact, for papers by Roser Solans Breakdown of academic impact, for papers by Fengchun Zhang Breakdown of academic impact, for papers by Micol Frassi Breakdown of academic impact, for papers by José María Pego‐Reigosa Breakdown of academic impact, for papers by Carlotta Nannini Breakdown of academic impact, for papers by Yan Zhao Breakdown of academic impact, for papers by H M Moutsopoulos
Rankless by CCL
2026